The early history of antibiotic discovery: Empiricism ruled

Antibiotic Discovery and Development

Volumn 9781461414001, Issue , 2012, Pages 3-31

  White, Richard J ^a  

^a HMB Biotechnology Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900873502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1400-1_1     Document Type: Chapter

References (74)

1. Abraham EP, Newton GG (1961) The structure of cephalosporin C. Biochem J 79:377-393
2. Abraham EP, Newton GG, Crawford K, Burton HS, Hale CW (1953) Cephalosporin N: a new type of penicillin. Nature 171:343
3. Batts DH, Koleff MH, Lipsky BA, Nicolau DP, Weigelt JA (eds) (2004) Creation of a novel class: the oxazolidinone antibiotics. Innova Institute for Medical Education, Tampa
4. Bérdy J (1980) CRC handbook of antibiotic compounds. CRC Press, Boca Raton
5. Bernheim F (1940) The effect of salicylate on the oxygen uptake of the tubercle bacillus. Science 92:204
6. Boothe JH, Morton J, Petisi JP, Wilkinson RG, Williams JH (1953) Tetracycline. J Am Chem Soc 75:4621
7. Brotzu G (1948) Ricerche su di un nouvo antibiotico. Lavori Dell'Instituto D'Igiene du Cagliari, pp 1-11
8. Bryskier A (2005) Antimicrobial agents: antibacterials and antifungals. ASM Press, Washington, DC
9. Bunch RL, McGuire JM (1952) Erythromycin, its salts and method of preparation. Eli Lilly, USA, pp 1-12
10. Burton HS, Abraham EP (1951) Isolation of antibiotics from a species of cephalosporium; cephalosporins P1, P2, P3, P4, and P5. Biochem J 50:168-174
11. Bycroft BW, Higton AA, Roberts AD (1988) Dictionary of antibiotics and related substances. Chapman and Hall, London
12. Clark RW (1985) The life of Ernst chain: penicillin and beyond. St. Martin's Press, New York
13. Cocito C (1979) Antibiotics of the virginiamycin family, inhibitors which contain synergistic components. Microbiol Rev 43:145-192
14. Conover LH, Moreland WT, English AR, Stephens CR, Pilgrim FJ (1953) Terramycin. XI. Tetracycline. J Am Chem Soc 75:4622-4623
15. Controulis J, Rebstock MC, Crooks HM (1949) Chloramphenicol (chloromycetin). IV. Synthesis. J Am Chem Soc 71:24563-22468
16. Cosar C, Julou L (1959) The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections. Ann Inst Pasteur 96:238-241 (Paris)
17. Debono M et al (1987) A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. J Antibiot 40:761-777 (Tokyo)
18. Domagk G (1935) Ein beitrag zur chemotherapieder bakteriellen infektionem. Deut Med Wochenschr 61:250-258
19. Dubos R (1939) Bactericidal effect of an extract of a soil bacillus on gram-positive bacteria. Proc Soc Exp Biol Med 40:311-312
20. Duggar BM (1948) Aureomycin; a product of the continuing search for new antibiotics. Ann N Y Acad Sci 51:177-181
21. Ehrlich J, Bartz QR, Smith RM, Joslyn DA, Burkholder PR (1947) Chloromycetin, a new antibiotic from a soil actinomycete. Science 106:417
22. Eliopoulos GM, Willey S, Reiszner E, Spitzer PG et al (1986) In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob Agents Chemother 30:532-535
23. Emmerson AM, Jones AM (2003) The quinolones: decades of development and use. J Antimicrob Chemother 51(Suppl S1):13-30
24. Finlay AC, Hobby GL et al (1950) Terramycin, a new antibiotic. Science 111:85
25. Fleming A (1929) Cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Brit J Exp Path 10:226-236
26. Fox HH (1953) The chemical attack on tuberculosis. Trans N Y Acad Sci 15:234-242
27. Gerzon K, Flynn EH, Sigal MV, Wiley PF, Monahan R, Quarck UC (1956) Erythromycin. VIII. Structure of dihydroerythronolide. J Am Chem Soc 78:6396-6408
28. Godtfredsen W, Roholt K, Tybring L (1962) Fucidin: a new orally active antibiotic. Lancet 1:928-931
29. Godtfredsen WO, Jahnsen S, Lorck H, Roholt K, Tybring L (1962) Fusidic acid: a new antibiotic. Nature 193:987
30. Harris DA, Reagan MA, Ruger M, Wallick H, Woodruff HB (1955) Discovery and antimicrobial properties of cathomycin, a new antibiotic produced by Streptomyces spheroides n. sp. Antibiot Annu 3:909-917
31. Hopwood DA (2007) Streptomyces in nature and medicine: the antibiotic makers. Oxford University Press, Oxford
32. Iwai Y, Omura S (1982) Culture conditions for screening of new antibiotics. J Antibiot 35: 123-141 (Tokyo)
33. Johnson BA, Anker H, Meleney fl(1945) Bacitracin: a new antibiotic produced by a member of the B. subtilis group. Science 102:376-377
34. Katz E, Demain AL (1977) The peptide antibiotics of bacillus: chemistry, biogenesis, and possible functions. Bacteriol Rev 41:449-474
35. Kucers A (1997) The use of antibiotics: a clinical review of antibacterial, antifungal, and antiviral drugs, 5th edn. Butterworth-Heinemann, Boston/Oxford
36. Kushner S et al (1952) Experimental chemotherapy of tuberculosis. II. The synthesis of pyrazinamides and related compounds. J Am Chem Soc 74:3617-3621
37. Lawrence P (2002) Rank injustice. Nature 415:835-836
38. Lazzarini A, Cavaletti L, Toppo G, Marinelli F (2000) Rare genera of actinomycetes as potential producers of new antibiotics. Antonie Van Leeuwenhoek 78:399-405
39. Lesher GY, Froelich EJ, Gruett MD, Bailey JH, Brundage RP (1962) 1, 8-naphthyridine derivatives. A new class of chemotherapeutic agents. J Med Pharm Chem 91:1063-1065
40. Levine DP (2006) Vancomycin: a history. Clin Infect Dis 42(Suppl 1):S5-S12
41. Lloyd NC, Morgan HW, Nicholson BK, Ronimus RS (2005) The composition of Ehrlich's salvarsan: resolution of a century-old debate. Angew Chem Int Ed Engl 44:941-944
42. Locci R (2005) La discuvierte dai antibiotics. Gentamicine: L'antibiotic che al a riscjat l'abort. Gjournal Furlan des siencis 6:129-137
43. Luedemann G (1991) Free spirit of enquiry: the uncommon common man in research and discovery. The Gentamicin story. The International Centre for Theoretical and Applied Ecology, Gorizia
44. Maeda K, Osato T, Umezawa H (1953) A new antibiotic, azomycin. J Antibiot 6:182 (Tokyo)
45. Maggi N, Pasqualucci CR, Ballotta R, Sensi P (1966) Rifampicin: a new orally active rifamycin. Chemotherapy 11:285-292
46. Mason DJ, Dietz A, Smith RM (1961) Actinospectacin, a new antibiotic. I. Discovery and biological properties. Antibiot Chemother 11:118-122
47. Mason DJ, Dietz A, Deboer C (1962) Lincomycin, a new antibiotic. I. Discovery and biological properties. It was an annual volume at that stage only later were there monthly issues. Antimicrob Agents Chemother: 554-559
48. McCormick MH, McGuire JM, Pittenger GE, Pittenger GC et al (1955) Vancomycin, a new antibiotic. I. Chemical and biological properties. Antibiot Annu 1955-56:606-611
49. McOsker CC, Fitzpatrick PM (1994) Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother 33(Suppl A):23-30
50. Mikusova K, Slayden RA, Besra GS, Brennan PJ (1995) Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39:2484-2489
51. Moberg CL, Cohn Z (1990) Launching the antibiotic era: personal accounts of the discovery and use of the first antibiotics. Rockefeller University Press, New York
52. Nakamura S (1955) Structure of azomycin, a new antibiotic. Pharm Bull 3:379-383
53. Oppolzer W, Prelog V, Sensi P (1964) The composition of rifamycin B and related rifamycins. Experientia 20:336-339
54. Preud'Homme J, Tarridec P, Belloc A (1968) Isolement de la pristinamycine et etude de ses principales proprietes physico-chimiques. Revue de Medecine 9:619-620
55. Rahman A-U, Ahmad VU (1990) Handbook of natural products data. Distributors for the U.S. and Canada, Elsevier Science, Amsterdam/New York
56. Rohlfing SR, Gerster JR, Kvam DC (1976) Bioevaluation of the antibacterial flumequine for urinary tract use. Antimicrob Agents Chemother 10:20-24
57. Ryan F (1993) The forgotten plague: how the battle against tuberculosis was won-and lost. Little, Brown/Boston, 1st American edn
58. Sensi P, Margalith P, Timbal MT (1959) Rifomycin, a new antibiotic; preliminary report. Farmaco (Sci) 14:146-147
59. Shinn DLS (1962) Metronidazole in acute ulcerative gingivitis. Lancet 279:1191
60. Smee AM et al (1987) Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob Agents Chemother 31: 1791-1797
61. Smith CG, Dietz A, Sokolski WT, Savage GM (1956) Streptonivicin, a new antibiotic. I. Discovery and biological studies. Antibiot Chemother 6:135-142
62. Sneader W (2005) Drug discovery: a history. Wiley, Hoboken
63. Stansly PG, Schlosser ME (1947) Studies on polymyxin: isolation and identification of Bacillus polymyxa and differentiation of polymyxin from certain known antibiotics. J Bacteriol 54:549-556
64. Stephens CH, Conover LH, Hochstein FA, Regna PP et al (1952) Terramycin. VIII. Structure of aureomycin and terramycin. J Am Chem Soc 74:4976-4977
65. Surrey AR, Hammer HF (1946) Some 7-substituted 4-aminoquinoline derivatives. J Am Chem Soc 68:113-116
66. Taylor FS (1971) The conquest of bacteria, from salvarsan to sulphapyridine. Books for Libraries Press, Freeport
67. Thomas JP, Baughn CO, Wilkinson RG, Shepherd RG (1961) A new synthetic compound with antituberculous activity in mice: ethambutol (dextro-2,2'-(ethylenediimino)-di-l-butanol). Am Rev Respir Dis 83:891-893
68. Umezawa H et al (1957) Production and isolation of a new antibiotic: kanamycin. J Antibiot 10:181-188 (Tokyo)
69. Wagman GH, Weinstein MJ (1980) Antibiotics from micromonospora. Annu Rev Microbiol 34:537-557
70. Waksman SA, Lechevalier HA (1949) Neomycin, a new antibiotic active against streptomycinresistant bacteria, including tuberculosis organisms. Science 109:305-307
71. Weinstein MJ et al (1963) Gentamicin, a new antibiotic complex from micromonospora. J Med Chem 6:463-464
72. Wilkinson S, Lowe LA (1963) Identities of the fatty acids derived from the polymyxins and colistin. Nature 200:1008-1009
73. Woods D (1940) The relation of p-aminobenzoic acid to the mechanism of action of sulphanilamide. Brit J Exp Pathol 21:74-90
74. Zimhony O, Cox JS, Welch JT, Vilcheze C, Jacobs WR Jr (2000) Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Nat Med 6:1043-1047